Asset Details
Do you wish to reserve the book?
Comparison of post-transplantation diabetes mellitus incidence and risk factors between kidney and liver transplantation patients
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Comparison of post-transplantation diabetes mellitus incidence and risk factors between kidney and liver transplantation patients
Do you wish to request the book?
Comparison of post-transplantation diabetes mellitus incidence and risk factors between kidney and liver transplantation patients
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Comparison of post-transplantation diabetes mellitus incidence and risk factors between kidney and liver transplantation patients
2020
Overview
Most prior studies characterizing post-transplantation diabetes mellitus (PTDM) have been limited to single-cohort, single-organ studies. This retrospective study determined PTDM across organs by comparing incidence and risk factors among 346 liver and 407 kidney transplant recipients from a single center.
Univariate and multivariate regression-based analyses were conducted to determine association of various risk factors and PTDM in the two cohorts, as well as differences in glucometrics and insulin use across time points.
There was a higher incidence of PTDM among liver versus kidney transplant recipients (30% vs. 19%) at 1-year post-transplant. Liver transplant recipients demonstrated a 337% higher odds association to PTDM (OR 3.37, 95% CI (1.38-8.25), p<0.01). 1-month FBG was higher in kidney patients (135 mg/dL vs 104 mg/dL; p < .01), while 1-month insulin use was higher in liver patients (61% vs 27%, p < .01). Age, BMI, insulin use, and inpatient FBG were also significantly associated with differential PTDM risk.
Kidney and liver transplant patients have different PTDM risk profiles, both in terms of absolute PTDM risk as well as time course of risk. Management of this population should better reflect risk heterogeneity to short-term need for insulin therapy and potentially long-term outcomes.
Publisher
Public Library of Science,Public Library of Science (PLoS)
Subject
/ Datasets
/ Diabetes
/ Diabetes Mellitus - diagnosis
/ Diabetes Mellitus - drug therapy
/ Diabetes Mellitus - etiology
/ Diabetes Mellitus - immunology
/ Fasting
/ Female
/ Glucose
/ Humans
/ Insulin
/ Kidney Transplantation - adverse effects
/ Kidneys
/ Liver
/ Liver Transplantation - adverse effects
/ Male
/ Medicine and Health Sciences
/ Organs
/ Patients
